Development of a hybrid cardiovascular graft using a tissue engineering approach

FASEB Journal

Volumn 16, Issue 8, 2002, Pages 791-796

  Tiwari, Alok ^a   Salacinski, Henryk J ^a   Punshon, Geoffrey ^a   Hamilton, George ^a   Seifalian, Alexander M ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Anticoagulant peptide; Covalent bonding; Endothelial cells; Hybrid graft; Spacer arm; X ray photoelectron spectroscopy

Indexed keywords

ANTICOAGULANT AGENT; ARGININE; ASPARTIC ACID; GLYCINE; HEPARIN; POLY(CARBONATE UREA)URETHANE; POLYMER; UNCLASSIFIED DRUG;

ARTERY BLOOD FLOW; ARTICLE; ASSAY; BLOOD VESSEL GRAFT; CELL VIABILITY; CHEMICAL ENGINEERING; CONTROLLED STUDY; COVALENT BOND; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FEMORAL ARTERY; GRAFT PATENCY; HUMAN; HUMAN CELL; HYBRID; ISOTOPE LABELING; METABOLIC ACTIVATION; PRIORITY JOURNAL; PULSATILE FLOW; SCINTILLATION CAMERA; SHEAR STRESS; TISSUE ENGINEERING; WAVEFORM; X RAY PHOTOELECTRON SPECTROSCOPY;

BLOOD VESSEL PROSTHESIS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBRONECTINS; HEPARIN; HUMANS; OLIGOPEPTIDES; POLYTETRAFLUOROETHYLENE; POLYURETHANES; TISSUE ENGINEERING;

EID: 0036273677     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0826com     Document Type: Article

References (30)

1. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass
2. Comparative evaluation of prosthetic, reversed, and in situ vein bypass graft in distal popliteal and tibial-peroneal revascularization
3. Noncompliance: The silent acceptance of a villain
4. Effect of compliance mismatch on vascular graft patency
5. A completely biological tissue-engineered human blood vessel
6. Compliance properties of conduits used in vascular reconstruction
7. A hybrid compliant vascular graft seeded with microvascular endothelial cells extracted from human omentum
8. New prostheses for use in bypass grafts with special emphasis on polyurethanes
9. In vitro stability of a novel compliant poly(carbonate-urea)urethane to oxidative and hydrolytic stress
10. Tissue engineering of vascular bypass grafts: Role of endothelial cell extraction
11. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: A 9-year experience
12. Effect of prolonged pulsatile shear stress in vitro on endothelial cell seeded PTFE and compliant polyurethane vascular grafts
13. Optimal endotheliaisation of a new compliant poly(carbonate-urea)urethane vascular graft with effect of physiological shear stress
14. New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts
15. Identification of an amino acid sequence in laminin mediating cell attachment chemotaxis, and receptor binding
16. Improvement of patency late in heparin-coated small synthetic vascular grafts
17. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial
18. Synthesis of a novel polyurethane copolymer containing covalently attached RGD peptide
19. Covalent attachment of an Arg-Gly-Asp sequence peptide to derivatizable polyacrylamide surfaces: Support of fibroblast adhesion and long-term growth
20. Synthesis, surface, and cell-adhesion properties of polyurethanes containing covalently grafted RGD-peptides
21. An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings: Its role in enhancing cellular retention
22. Development and evaluation of all ideal flow circuit: Assessing the dynamic behavior of endothelial seeded grafts
23. A new technique fur measuring the cell growth and metabolism of endothelial cells seeded on vascular prostheses
24. Cellular engineering of vascular bypass grafts: Role of chemical coatings for enhancing endothelial cell attachment
25. Fibronectin coating of expanded polytetrafluoroethylene (ePTFE) grafts and its role in endothelial seeding
26. Improved endothelial cell attachment un ePTFE vascular grafts pretreated with synthetic RGD-containing peptides
27. Differences in sulfation pattern of heparin surface
28. Fibronectins
29. Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts